Accomplishments

Successfully completed US FDA Remote Regulatory Assessment at our Analytical Testing Facility (CLAS)

Successfully commercialized Remdesivir & Favipiravir which were authorized in emergency treatment of Covid-19.

Dedicated Ibupforen manufacturing block inaugurated.

Successfully completed EU GMP inspection by EDQM at our Bachupally facility.

Successfully completed 3rd US FDA inspection at our Vijayanagaram facility.

Successfully completed 1st US FDA inspection at our Analytical Testing Facility (CLAS)

Central Laboratory Analytical Services (CLAS) established to cater analytical services using hyphenated analytical techniques.

Demerged SMS group into 2 Entities – SMS Pharmaceuticals, SMS Lifesciences.

Successfully completed PMDA- Japan inspection at our Bachupally facility.

Successfully completed 5th US FDA inspection at our Bachupally facility.

Successfully completed 2nd US FDA inspection at our Vijayanagaram facility.

Won the prestigious “Indian Pharma Bulk drug company of the year” award and “Best bulk drug export company of the year” award from Govt. of India.

Renewal of EU-GMP certification by Hamburg Health Authority (BGV) is successful at our Bachupally facility.

Successfully completed 4th US FDA inspection at our Bachupally facility.

Commercial production started in our world class API facility, Vijayanagaram.

Successfully completed 1st US FDA inspection at our Vijayanagaram facility.

Successfully completed 3rd US FDA inspection at our Bachupally facility.

EU-GMP certification by Hamburg Health Authority (BGV) is successful at our Bachupally facility.

Started a green field project to build an API facility in more than 100 acres of Land.

DSIR recognized our Gagillapur R&D center.

Successfully completed 2nd US FDA inspection at our Bachupally facility.

Inauguration of state of the art R&D Center at Gagillapur, Hyderabad.

SMS got listed on the NSE, BSE (Indian stock exchange) – Public Listed company.

DSIR recognized our in-house R&D center.

In-house R&D center established at Sanath Nagar, Hyderabad.

Faced our first USFDA audit (successfully); SMS API was Part of a Para IV filing from an MCN company.

Successfully commercialized Sumatriptan Succinate at our Bachupally facility.

Recognized by govt. of India with a Jawaharlal Silver rolling trophy for the best productivity of the year.

Became the Largest manufacturer of Ranitidine API in the world.

SMS Pharma was started with single Unit, single product facility.